# Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD

> **NCT02621593** · NA · COMPLETED · sponsor: **Lumenis Be Ltd.** · enrollment: 44 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DEVICE:** M22-IPL

## Key facts

- **NCT ID:** NCT02621593
- **Lead sponsor:** Lumenis Be Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02621593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02621593, "Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02621593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*